A detailed history of Cetera Investment Advisers transactions in Ocugen, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 414,701 shares of OCGN stock, worth $306,878. This represents 0.0% of its overall portfolio holdings.

Number of Shares
414,701
Holding current value
$306,878
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.98 - $1.95 $406,406 - $808,666
414,701 New
414,701 $410,000
Q3 2022

Nov 10, 2022

SELL
$1.75 - $3.1 $3,325 - $5,890
-1,900 Reduced 12.47%
13,332 $24,000
Q1 2022

May 13, 2022

BUY
$2.34 - $4.72 $35,642 - $71,895
15,232 New
15,232 $50,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $160M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.